{
  "id": 11273683,
  "title": "GLP-1 prescriptions for new mothers have increased sharply",
  "url": "https://urgent.news/2026/10/01/glp-1-prescriptions-for-new-mothers-have-increased-sharply",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T20:20:14.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-glp-prescriptions-mothers-sharply.html"
  },
  "original_language": "en",
  "account": "New mothers in the United States are being prescribed GLP-1 medications, including Ozempic and Zepbound, at an unprecedented rate following birth, according to research from the USC Schaeffer Center for Health Policy & Economics. The study, published in JAMA, reveals a 24-fold increase in new prescriptions for these diabetes and weight-loss drugs among postpartum women over a seven-year period. The surge was particularly notable among women diagnosed with diabetes, with the rate of GLP-1 prescriptions for this group rising from 2.3% in 2021 to 16.9% by 2025. Gestational diabetes, which develops during pregnancy, also saw a substantial increase in GLP-1 prescription rates, from 0.4% in mid-2021 to 2.7% in the first quarter of 2025. Overweight and obese women before pregnancy accounted for the fastest growth in GLP-1 prescriptions since late 2024, making up 40% of new users by the second half of 2024. Despite the significant rise in postpartum GLP-1 usage, the study highlights the need for further research on the safety of these medications during breastfeeding.",
  "summary": "More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}